CrkII transgene induces atypical mammary gland development and tumorigenesis

American Journal of Pathology

Volumn 176, Issue 1, 2010, Pages 446-460

  Fathers, Kelly E ^a   Rodrigues, Sonia ^a,c   Zuo, Dongmei ^a   Murthy, Indrani Vasudeva ^a   Hallett, Michael ^a   Cardiff, Robert ^b   Park, Morag ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CRKII PROTEIN; CYTOKERATIN; HORMONE; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; BREAST TUMOR; CARCINOGENESIS; CONTROLLED STUDY; CRKII TRANSGENE; DISEASE COURSE; FEMALE; IN VIVO STUDY; LATENT PERIOD; MAMMARY GLAND; MORPHOGENESIS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PUBERTY; TRANSGENE; TRANSGENIC MOUSE;

EID: 73949113400     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090383     Document Type: Article

References (55)

1. Mayer BJ, Hamaguchi M, Hanafusa H: A novel viral oncogene with structural similarity to phospholipase C. Nature 1988, 332:272-275
2. Feller SM: Crk family adaptors-signalling complex formation and biological roles. Oncogene 2001, 20:6348-6371
3. ten Hoeve J, Morris C, Heisterkamp N, Groffen J: Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene 1993, 8:2469-2474
4. Reichman CT, Mayer BJ, Keshav S, Hanafusa H: The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ 1992, 3:451-460
5. Lamorte L, Royal I, Naujokas M, Park M: Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions. Mol Biol Cell 2002, 13:1449-1461
6. Lamorte L, Rodrigues S, Naujokas M, Park M: Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic program. J Biol Chem 2002, 277:37904-37911
7. Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, Misek DE, Giordano TJ, Yee J, Orringer MB, Hanash SM, Beer DG: Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene 2003, 22:7950-7957
8. Rodrigues SP, Fathers KE, Chan G, Zuo D, Halwani F, Meterissian S, Park M: CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells. Mol Cancer Res 2005, 3:183-194
9. Nishihara H, Tanaka S, Tsuda M, Oikawa S, Maeda M, Shimizu M, Shinomiya H, Tanigami A, Sawa H, Nagashima K: Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett 2002, 180:55-61
10. Takino T, Nakada M, Miyamori H, Yamashita J, Yamada KM, Sato H: CrkI adapter protein modulates cell migration and invasion in glioblastoma. Cancer Res 2003, 63:2335-2337
11. Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M: Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol 1992, 12:3482-3489
12. Iwahara T, Akagi T, Shishido T, Hanafusa H: CrkII induces serum response factor activation and cellular transformation through its function in Rho activation. Oncogene 2003, 22:5946-5957
13. Senechal K, Halpern J, Sawyers CL: The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCRABL oncogene. J Biol Chem 1996, 271:23255-23261
14. Hemmeryckx B, van Wijk A, Reichert A, Kaartinen V, de Jong R, Pattengale PK, Gonzalez-Gomez I, Groffen J, Heisterkamp N: Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice. Cancer Res 2001, 61:1398-1405
15. White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ: Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004, 6:159-170
16. Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff RD, McLean GW, Frame MC, Muller WJ: Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci USA 2007, 104:20302-20307
17. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M: Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008, 14:518-527
18. Finak G, Sadekova S, Pepin F, Hallett M, Meterissian S, Halwani F, Khetani K, Souleimanova M, Zabolotny B, Omeroglu A, Park M: Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res 2006, 8:R58
19. Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L: Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 2001, 10:545-553
20. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM: An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 2000, 5:227-241
21. Hinck L, Silberstein GB: Key stages in mammary gland development: the mammary end bud as a motile organ. Breast Cancer Res 2005, 7:245-251
22. Wang W, Morrison B, Galbaugh T, Jose CC, Kenney N, Cutler ML: Glucocorticoid induced expression of connective tissue growth factor contributes to lactogenic differentiation of mouse mammary epithelial cells. J Cell Physiol 2008, 214:38-46
23. Schneiders FI, Maertens B, Bose K, Li Y, Brunken WJ, Paulsson M, Smyth N, Koch M: Binding of netrin-4 to laminin short arms regulates basement membrane assembly. J Biol Chem 2007, 282:23750-23758
24. Liu Y, Stein E, Oliver T, Li Y, Brunken WJ, Koch M, Tessier-Lavigne M, Hogan BL: Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. Curr Biol 2004, 14:897-905
25. Schwertfeger KL, Rosen JM, Cohen DA: Mammary gland macrophages: pleiotropic functions in mammary development. J Mammary Gland Biol Neoplasia 2006, 11:229-238
26. Nikolova Z, Djonov V, Zuercher G, Andres AC, Ziemiecki A: Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci 1998, 111 (Pt 18):2741-2751
27. Kar B, Reichman CT, Singh S, O'Connor JP, Birge RB: Proapoptotic function of the nuclear Crk II adaptor protein. Biochemistry 2007, 46:10828-10840
28. Fish EN, Uddin S, Korkmaz M, Majchrzak B, Druker BJ, Platanias LC: Activation of a CrkL-stat5 signaling complex by type I interferons. J Biol Chem 1999, 274:571-573
29. Nautiyal J, Kumar PG, Laloraya M: 17Beta-estradiol induces nuclear translocation of CrkL at the window of embryo implantation. Biochem Biophys Res Commun 2004, 318:103-112
30. Ozaki K, Oda A, Wakao H, Rhodes J, Druker BJ, Ishida A, Wakui M, Okamoto S, Morita K, Handa M, Komatsu N, Ohashi H, Miyajima A, Ikeda Y: Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets. Blood 1998, 92:4652-4662
31. Rhodes J, York RD, Tara D, Tajinda K, Druker BJ: CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells. Exp Hematol 2000, 28:305-310
32. Vargo-Gogola T, Heckman BM, Gunther EJ, Chodosh LA, Rosen JM: P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland. Mol Endocrinol 2006, 20: 1391-1405
33. Wechselberger C, Strizzi L, Kenney N, Hirota M, Sun Y, Ebert A, Orozco O, Bianco C, Khan NI, Wallace-Jones B, Normanno N, Adkins H, Sanicola M, Salomon DS: Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene 2005, 24:4094-4105
34. Stairs DB, Notarfrancesco KL, Chodosh LA: The serine/threonine kinase. Krct, affects endbud morphogenesis during murine mammary gland development. Transgenic Res 2005, 14:919-940
35. Weinstein EJ, Leder P: The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis. Cancer Res 2000, 60:3856-3861
36. Srinivasan K, Strickland P, Valdes A, Shin GC, Hinck L: Netrin-1/ neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev Cell 2003, 4:371-382
37. Strizzi L, Mancino M, Bianco C, Raafat A, Gonzales M, Booth BW, Watanabe K, Nagaoka T, Mack DL, Howard B, Callahan R, Smith GH, Salomon DS: Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland. J Cell Physiol 2008, 216:824 -834
38. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM: Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254
39. Cabodi S, Tinnirello A, Di Stefano P, Bisaro B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P: p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 2006, 66:4672-4680
40. Rauh MJ, Blackmore V, Andrechek ER, Tortorice CG, Daly R, Lai VK, Pawson T, Cardiff RD, Siegel PM, Muller WJ: Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein. Mol Cell Biol 1999, 19:8169-8179
41. Niemann C, Brinkmann V, Spitzer E, Hartmann G, Sachs M, Naundorf H, Birchmeier W: Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J Cell Biol 1998, 143:533-545
42. Pepper MS, Soriano JV, Menoud PA, Sappino AP, Orci L, Montesano R: Modulation of hepatocyte growth factor and c-met in the rat mammary gland during pregnancy, lactation, and involution. Exp Cell Res 1995, 219:204-210
43. Xie W, Paterson AJ, Chin E, Nabell LM, Kudlow JE: Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol 1997, 11:1766-1781
44. Ruan W, Kleinberg DL: Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 1999, 140:5075-5081
45. Wakefield LM, Thordarson G, Nieto AI, Shyamala G, Galvez JJ, Anver MR, Cardiff RD: Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med 2003, 53:424-432
46. Nieto AI, Shyamala G, Galvez JJ, Thordarson G, Wakefield LM, Cardiff RD: Persistent mammary hyperplasia in FVB/N mice. Comp Med 2003, 53:433-438
47. Bentires-Alj M, Gil SG, Chan R, Wang ZC, Wang Y, Imanaka N, Harris LN, Richardson A, Neel BG, Gu H: A role for the scaffolding adapter GAB2 in breast cancer. Nat Med 2006, 12:114-121
48. Abassi YA, Vuori K: Tyrosine 221 in Crk regulates adhesion-dependent membrane localization of Crk and Rac and activation of Rac signaling. EMBO J 2002, 21:4571-4582
49. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA: CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol 1998, 140:961-972
50. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F: Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat Struct Mol Biol 2007, 14:503-510
51. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, Varmus HE: Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 2003, 100: 15853-15858
52. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874
53. Fadare O, Tavassoli FA: Clinical and pathologic aspects of basal-like breast cancers. Nat Clin Pract Oncol 2008, 5:149-159
54. Kouros-Mehr H, Werb Z: Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn 2006, 235:3404-3412
55. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z: Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 2008, 14:570-581